Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 939

    2.

    Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

    Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, Portha B.

    Diabetes. 2002 May;51(5):1443-52.PMID: 11978641 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.

    Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ.

    J Biol Chem. 2003 Jan 3;278(1):471-8. Epub 2002 Oct 29.PMID: 12409292 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.

    Dachicourt N, Serradas P, Bailbé D, Kergoat M, Doaré L, Portha B.

    J Endocrinol. 1997 Nov;155(2):369-76.PMID: 9415071 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.

    Parkes DG, Pittner R, Jodka C, Smith P, Young A.

    Metabolism. 2001 May;50(5):583-9.PMID: 11319721 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.

    Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.

    J Mol Endocrinol. 2005 Aug;35(1):27-38.PMID: 16087719 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

    Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, Pederson RA.

    Diabetes. 2003 Mar;52(3):741-50.PMID: 12606516 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.

    Ozyazgan S, Kutluata N, Afşar S, Ozdaş SB, Akkan AG.

    Pharmacology. 2005 Jun;74(3):119-26. Epub 2005 Mar 3.PMID: 15746570 [PubMed - indexed for MEDLINE]Related articles

    10.

    Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

    Xu G, Stoffers DA, Habener JF, Bonner-Weir S.

    Diabetes. 1999 Dec;48(12):2270-6.PMID: 10580413 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations.

    Greig NH, Holloway HW, De Ore KA, Jani D, Wang Y, Zhou J, Garant MJ, Egan JM.

    Diabetologia. 1999 Jan;42(1):45-50.PMID: 10027577 [PubMed - indexed for MEDLINE]Related articles

    12.

    Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

    Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R.

    Endocrinology. 2002 Nov;143(11):4397-408.PMID: 12399437 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.

    Sjöholm A, Sandberg E, Ostenson CG, Efendić S.

    Pancreas. 2000 Apr;20(3):282-9.PMID: 10766455 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.

    Movassat J, Saulnier C, Serradas P, Portha B.

    Diabetologia. 1997 Aug;40(8):916-25.PMID: 9267986 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glucagon-like peptide-1.

    Doyle ME, Egan JM.

    Recent Prog Horm Res. 2001;56:377-99. Review.PMID: 11237222 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Insulin secretion and glucose tolerance after islet transplantation in rats with noninsulin-dependent diabetes induced by neonatal streptozotocin.

    Tormo MA, Leon-Quinto T, Saulnier C, Bailbe D, Serradas P, Portha B.

    Cell Transplant. 1997 Jan-Feb;6(1):23-32.PMID: 9040952 [PubMed - indexed for MEDLINE]Related articles

    17.

    Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight.

    Gedulin BR, Nikoulina SE, Smith PA, Gedulin G, Nielsen LL, Baron AD, Parkes DG, Young AA.

    Endocrinology. 2005 Apr;146(4):2069-76. Epub 2004 Dec 23.PMID: 15618356 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.

    Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM.

    J Endocrinol. 2005 Jun;185(3):457-65.PMID: 15930172 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.

    Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC.

    Diabetes. 1996 Nov;45(11):1524-30.PMID: 8866556 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats.

    Irako T, Akamizu T, Hosoda H, Iwakura H, Ariyasu H, Tojo K, Tajima N, Kangawa K.

    Diabetologia. 2006 Jun;49(6):1264-73. Epub 2006 Mar 29.PMID: 16570155 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data